MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Total Assets History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Assets | ₹27,652 Cr | ₹11,883 Cr | ₹9,686 Cr | ₹9,108 Cr | ₹6,324 Cr |
What is the latest Total Assets ratio of MANKIND PHARMA ?
Year | Total Assets |
---|---|
Mar2025 | ₹27,652 Cr |
Mar2024 | ₹11,883 Cr |
Mar2023 | ₹9,686 Cr |
Mar2022 | ₹9,108 Cr |
Mar2021 | ₹6,324 Cr |
How is Total Assets of MANKIND PHARMA Trending?
Years | Total Assets | % Change | |
---|---|---|---|
Mar2025 | ₹27,652 Cr | 132.70 | |
Mar2024 | ₹11,883 Cr | 22.68 | |
Mar2023 | ₹9,686 Cr | 6.34 | |
Mar2022 | ₹9,108 Cr | 44.04 | |
Mar2021 | ₹6,324 Cr | - |
Compare Total Assets of peers of MANKIND PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MANKIND PHARMA | ₹108,001.5 Cr | 1.6% | 8.4% | 31.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
MANKIND PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MANKIND PHARMA | 1.6% |
8.4% |
31.6% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses